Vertex announced U.S. FDA approval for TRIKAFTA in children with cystic fibrosis ages 2 through 5 with certain mutations
On Apr. 26, 2023, Vertex announced the Food and Drug Administration (FDA) had approved the expanded use of…
On Apr. 26, 2023, Vertex announced the Food and Drug Administration (FDA) had approved the expanded use of…
On Apr. 18, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening for…
On Apr. 17, 2023, a new initiative led by Jennifer Doudna and Jill Banfield at the Innovative Genomics…
On Apr. 13, 2023, in an enormous leap forward in the understanding of Parkinson’s disease (PD), researchers announced…
On Apr. 11, 2023, a National Institutes of Health (NIH) clinical trial was stopped early because a daily…
On Apr. 3, 2023, a study from the National Eye Institute (NEI) identified rare genetic variants that could…
On Mar. 29, 2023, the World Health Organization (WHO) announced that it had certified Azerbaijan and Tajikistan for…
On Mar. 20, 2023, the Centers for Disease Control and Prevention (CDC) reported that Candida auris (C. auris),…
On Mar. 13, 2023, the U.S. Food and Drug Administration (FDA) announced that it had approved Acadia Pharmaceuticals’…
On Mar. 9, 2023, the U.S. Food and Drug Administration (FDA) announced that it had published updates to…
On Feb. 14, 2023, the Pacific Economic Development Agency of Canada (PacifiCan), announced $14.5 million in funding for…
On Feb. 3, 2023, the World Health Organization (WHO) released an updated Global Breast Cancer Initiative (GBCI) Framework…
On Feb. 2, 2023, a National Institutes of Health research group with extensive experience studying ebolavirus countermeasures successfully…
On Jan. 31, 2023, a team of researchers led by the Innovation Center for Neurological Disorders and Department…
On Jan. 25, 2023, it was reported that adults living in rural areas of the United States have…
The Milestones in CRISPR cartoon illustrates several significant achievements in the development of the technology with commentary by…
On Jan. 11, 2023, Uganda declared the end of the Ebola disease outbreak caused by Sudan ebolavirus, less…
On Jan. 4, 2023, an international research group announced it had for the first time reconstructed ancestors dating…
On Dec. 10, 2022, CSL announced data affirming the long-term durability and safety of single-infusion HEMGENIX® (etranacogene dezaparvovec-drlb)…
On Nov. 22, 2022, the U.S. Food and Drug Administration approved the investigational gene therapy etranacogene dezaparvovec or…
On Nov. 17, 2022, the U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) injection to delay the…
On Nov. 16, 2022, researchers at the National Institutes of Health (NIH) announced they had successfully identified differences…
On Nov. 1, 2022, the National Institutes of Health (NIH) announced that adults with hypertension saw a small,…
On Oct. 27, 2022, the National Institutes of Health (NIH) announced that overall cancer death rates continued to…
On Oct. 26, 2022, the Barbara Ann Karmanos Cancer Institute announced it had completed an over 50,000-square-foot expansion…
On Oct. 15, 2022, scientists reported that DNA evidence showed that the plague infection was endemic in the…
On Sept. 29, 2022, the World Health Organization announced that it had identified the spread of Anopheles stephensi…
On Sept. 27, 2022, the National Institutes of Health (NIH) announced it had launched a program to better…
On Sept. 20, 2022, The health authorities in Uganda declared an outbreak of Ebola after a case of…
On Sept. 17, 2022, the Democratic Republic of the Congo declared the end of an Ebola outbreak that…